California Jury Awards $25 Million to Man Who Developed Popcorn Lung From PAM Cooking Spray
Won by TorHoerman Law.
A Los Angeles jury unanimously held Conagra Brands fully liable and awarded $25 million to Roland Esparza, who developed severe bronchiolitis obliterans after years of daily exposure to butter-flavored PAM cooking spray fumes.
What happened
Roland Esparza used butter-flavored PAM nonstick cooking spray in his home kitchen multiple times a day for years. Over time, he began experiencing worsening respiratory symptoms that doctors eventually traced to bronchiolitis obliterans, a rare and irreversible lung disease caused by scarring and inflammation of the small airways. The condition is sometimes called popcorn lung because it was first identified in workers at microwave-popcorn factories who inhaled diacetyl, the synthetic butter-flavoring compound.
Esparza filed suit in 2020, alleging that the butter-flavored PAM spray made by Conagra Brands contained diacetyl and related flavor chemicals that created inhalation hazards the company failed to disclose. By the time the case reached trial, his lung function had deteriorated to the point where he required supplemental oxygen around the clock and was on a waiting list for a double lung transplant.
At trial, TorHoerman Law attorneys Jake Plattenberger and Alan Holcomb argued that Conagra knew, or should have known, that diacetyl vapors released during normal spray-can use posed a serious inhalation risk to consumers. Conagra maintained that it had removed diacetyl from the product's formulation in 2009, but the jury found that argument unpersuasive. The panel held the company fully responsible for Esparza's injuries.
On February 4, 2026, the jury returned a unanimous verdict of $25 million, covering Esparza's past and future medical costs, pain and suffering, and loss of quality of life. Plaintiff's counsel described it as the largest consumer verdict in a diacetyl lung-injury case to date. Conagra publicly disagreed with the outcome and announced plans to appeal.
The verdict drew coverage from Bloomberg Law and Law360, both of which confirmed the unanimous jury finding and the $25 million award. No post-verdict reduction had been reported as of publication.
Sources
This account is drawn from contemporaneous public reporting and the court record.
More proven verdicts from TorHoerman Law
All TorHoerman Law proven verdicts →Boehringer Ingelheim agreed to pay $650 million in May 2014 to resolve approximately 4,000 federal lawsuits claiming the blood thinner Pradaxa caused life-threatening bleeding injuries without adequate warnings, in an MDL presided over by Judge David Herndon in the Southern District of Illinois where the court appointed TorHoerman Law's Tor Hoerman as one of five plaintiffs' co-lead counsel.
A St. Louis jury awarded $495 million against Abbott Laboratories after finding the company failed to warn that its Similac cow's milk formula could cause necrotizing enterocolitis in premature infants.
A federal jury in St. Louis awarded $25 million to the parents of a two-year-old girl who drowned after climbing into a Bestway above-ground pool using an exterior nylon strap the manufacturer had built into the design.
A St. Louis jury found diacetyl distributor Elan Chemical Company liable for the debilitating lung disease suffered by two food-flavoring plant workers, returning a $1 million verdict for each man in March 2023.
Related product liability verdicts
Sullivan Papain was among the firms representing New York State against Philip Morris, R.J. Reynolds, Brown & Williamson, and Lorillard, securing a $25 billion recovery through the 1998 Master Settlement Agreement.
C. Steven Yerrid, the youngest of Florida's 11-lawyer 'Dream Team,' added racketeering and conspiracy charges that tripled the damages ceiling, helping the state secure what was then the largest civil settlement in American history against the tobacco industry.
As co-lead counsel in the federal Roundup multidistrict litigation and the first firm to sue Monsanto in 2015, Weitz and Luxenberg helped negotiate a $10.9 billion settlement resolving approximately 125,000 non-Hodgkin lymphoma claims against Bayer-owned Monsanto.
After fifteen years of litigation and three failed bankruptcy maneuvers by Johnson and Johnson subsidiaries, Ashcraft and Gerel attorneys R. Bryant McCulley and Michelle Parfitt helped negotiate a global, uncapped settlement of at least $5.5 billion covering approximately 76,000 ovarian-cancer claims.